At a glance
ClinicalIndex Comparison RecordN/ACompleted· 129 enrolled
Drug / intervention
FlareHawk Interbody Fusion Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Transforaminal/Posterior Lumbar Interbody Fusion With the FlareHawk® Expandable Interbody Fusion Device: A Retrospective Chart Review Study
In Brief
An observational study evaluating FlareHawk Interbody Fusion System for Degenerative Disc Disease. Completed, enrolled 129 participants across 3 sites.
Detailed Summary
This is a retrospective clinical study (chart review) of patients who have previously undergone Transforaminal Lumbar Interbody Fusion or Posterior Lumbar Interbody Fusion surgery with the FlareHawk expandable interbody fusion cage at one or two contiguous levels.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDegenerative Disc Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedAug 2019
Enrollment StartSep 2019
Primary CompletionDec 2019
Study CompletionDec 2019
TodayJul 2026
First PostedAug 15, 2019
Enrollment StartSep 23, 2019
Primary CompletionDec 13, 2019
Study CompletionDec 18, 2019
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 6.9 years ago
Interventions
FlareHawk Interbody Fusion Systemdevice
Expandable lumbar intervertebral body fusion device